Growth Metrics

Conmed (CNMD) Cash from Operations (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Conmed 1.06 Bn 1.02 Bn 183.45 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -70.92%
Dec 31, 2025 -13.69%
Sep 30, 2025 84.27%
Jun 30, 2025 -29.86%
Mar 31, 2025 -4.16%
Dec 31, 2024 -15.36%
Sep 30, 2024 18.24%
Jun 30, 2024 48.71%
Mar 31, 2024 -48.36%
Dec 31, 2023 22.26%
Sep 30, 2023 72.94%
Jun 30, 2023 793.35%
Mar 31, 2023 66.83%
Dec 31, 2022 -144.79%
Sep 30, 2022 38.15%
Jun 30, 2022 5,614.02%
Mar 31, 2022 -99.03%
Dec 31, 2021 58.15%
Sep 30, 2021 -37.68%
Jun 30, 2021 53.41%
Mar 31, 2021 10.92%
Dec 31, 2020 -42.65%
Sep 30, 2020 534.16%
Jun 30, 2020 48.86%
Mar 31, 2020 -90.90%
Dec 31, 2019 11.68%
Sep 30, 2019 69.63%
Jun 30, 2019 650.43%
Mar 31, 2019 -115.87%
Dec 31, 2018 467.75%
Sep 30, 2018 -78.90%
Jun 30, 2018 -17.57%
Mar 31, 2018 20.23%
Dec 31, 2017 54.99%
Sep 30, 2017 -16.22%
Jun 30, 2017 4.77%
Mar 31, 2017 11.72%
Dec 31, 2016 -44.70%
Sep 30, 2016 37.69%
Jun 30, 2016 208.61%
Mar 31, 2016 -235.75%
Dec 31, 2015 -10.74%
Sep 30, 2015 33.37%
Jun 30, 2015 -30.81%
Mar 31, 2015 -42.26%
Dec 31, 2014 75.47%
Sep 30, 2014 85.29%
Jun 30, 2014 -53.67%
Mar 31, 2014 -37.66%
Dec 31, 2013 -10.41%
Sep 30, 2013 72.40%
Jun 30, 2013 223.14%
Mar 31, 2013 -83.88%
Dec 31, 2012 21.26%
Sep 30, 2012 9.12%
Jun 30, 2012 236.19%
Mar 31, 2012 -70.97%
Dec 31, 2011 -27.96%
Sep 30, 2011 86.89%
Jun 30, 2011 -5.69%
Mar 31, 2011 -9.82%
Dec 31, 2010 135.01%